Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

The Faculty of Medicine - Immunology and Cancer Research: Ben-Sasson Zami


Last updated December 2021 -  Immunology and Cancer Research

List of Publications

(1) Tsabari R, Simchovitz E, Lavi E, Eliav O, Avrahami R, Ben-Sasson S, et al. Safety and clinical outcome of tamoxifen in Duchenne muscular dystrophy. Neuromuscular Disord 2021;31(9):803-813.

(2) Lei R, Hou J, Chen Q, Yuan W, Cheng B, Sun Y, et al. Self-Assembling Myristoylated Human α-Defensin 5 as a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection. ACS Nano 2018;12(6):5284-5296.

(3) Anzi S, Stolovich-Rain M, Klochendler A, Fridlich O, Helman A, Paz-Sonnenfeld A, et al. Postnatal Exocrine Pancreas Growth by Cellular Hypertrophy Correlates with a Shorter Lifespan in Mammals. Dev Cell 2018;45(6):726-737.e3.

(4) Hou J, Chen Q, Wu X, Zhao D, Reuveni H, Licht T, et al. S1PR3 signaling drives bacterial killing and is required for survival in bacterial sepsis. Am J Respir Crit Care Med 2017;196(12):1559-1570.

(5) Hogg A, Sui Y, Ben-Sasson SZ, Paul WE, Berzofsky JA. Role of CD4 T cell helper subsets in immune response and deviation of CD8 T cells in mice*. Eur J Immunol 2017;47(12):2059-2069.

(6) Ben-Yehuda Greenwald M, Frušić-Zlotkin M, Soroka Y, Ben-Sasson S, Bianco-Peled H, Kohen R. A novel role of topical iodine in skin: Activation of the Nrf2 pathway. Free Radic Biol Med 2017;104:238-248.

(7) Ben Yehuda Greenwald M, Frušić-Zlotkin M, Soroka Y, Ben Sasson S, Bitton R, Bianco-Peled H, et al. Curcumin Protects Skin against UVB-Induced Cytotoxicity via the Keap1-Nrf2 Pathway: The Use of a Microemulsion Delivery System. Oxidative Med Cell Longevity 2017;2017.

(8) Greenwald MB-, Ben-Sasson S, Bianco-Peled H, Kohen R. Skin redox balance maintenance: The need for an Nrf2-activator delivery system. Cosmetics 2016;3(1).

(9) Ben Yehuda Greenwald M, Anzi S, Ben Sasson S, Bianco-Peled H, Kohen R. Can nitroxides evoke the Keap1-Nrf2-ARE pathway in skin? Free Radic Biol Med 2014;77:258-269.

(10) Vang AG, Housley W, Dong H, Basole C, Ben-Sasson SZ, Kream BE, et al. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: A potential role for Epac. Biochem J 2013;456(3):463-473.

(11) Wüthrich M, Lebert V, Galles K, Hu-Li J, Ben-Sasson SZ, Paul WE, et al. Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against blastomyces dermatitidis infection. J Infect Dis 2013;208(7):1175-1182.

(12) Ben Yehuda Greenwald M, Ben Sasson S, Bianco-Peled H. A new method for encapsulating hydrophobic compounds within cationic polymeric nanoparticles. J Microencapsulation 2013;30(6):580-588.

(13) Hurevich M, Ratner-Hurevich M, Tal-Gan Y, Shalev DE, Ben-Sasson SZ, Gilon C. Backbone cyclic helix mimetic of chemokine (C-C motif) receptor 2: A rational approach for inhibiting dimerization of G protein-coupled receptors. Bioorg Med Chem 2013;21(13):3958-3966.

(14) Ben-Sasson SZ, Hogg A, Hu-Li J, Wingfield P, Chen X, Crank M, et al. IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells. J Exp Med 2013;210(3):491-502.

(15) Ben-Sasson SZ, Wang K, Cohen J, Paul WE. IL-1β strikingly enhances antigen-driven CD4 and CD8 T-cell responses. Cold Spring Harbor Symp Quant Biol 2013;78(1):117-124.

(16) Ben-Sasson SZ, Caucheteux S, Crank M, Hu-Li J, Paul WE. IL-1 acts on T cells to enhance the magnitude of in vivo immune responses. Cytokine 2011;56(1):122-125.

(17) Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, et al. TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. PLoS ONE 2011;6(7).

(18) Quiel J, Caucheteux S, Laurence A, Singh NJ, Bocharov G, Ben-Sasson SZ, et al. Antigen-stimulated CD4 T-cell expansion is inversely and log-linearly related to precursor number. Proc Natl Acad Sci U S A 2011;108(8):3312-3317.

(19) Vang AG, Ben-Sasson SZ, Dong H, Kream B, de Ninno MP, Claffey MM, et al. PDE8 regulates rapid teff cell adhesion and proliferation independent of ICER. PLoS ONE 2010;5(8).

(20) Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A 2009;106(17):7119-7124.

(21) Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Immunol 2008;181(5):2943-2951.

(22) Ben-Sasson SA, Grover NB. Erratum: Osmosis: A macroscopic phenomenon, a microscopic view (American Journal of Physiology - Advances in Physiology Education (2003) 27, (15-19)). Am J Physiol Adv Physiol Educ 2007;31(2):245.

(23) Riss J, Khanna C, Koo S, Chandramouli GVR, Yang HH, Hu Y, et al. Cancers as wounds that do not heal: Differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res 2006;66(14):7216-7224.

(24) Strehblow C, Sperker W, Hevesi A, Garamvölgyi R, Petrasi Z, Shirazi M, et al. Paradoxical effects of aurintricarboxylic acid and RG-13577: Acute thrombosis and in-stent stenosis in a passive-coated stent. J Endovasc Ther 2006;13(1):94-103.

(25) Rochman I, Paul WE, Ben-Sasson SZ. IL-6 increases primed cell expansion and survival. J Immunol 2005;174(8):4761-4767.

(26) Goldenberg-Furmanov M, Stein I, Pikarsky E, Rubin H, Kasem S, Wygoda M, et al. Lyn Is a Target Gene for Prostate Cancer: Sequence-Based Inhibition Induces Regression of Human Tumor Xenografts. Cancer Res 2004;64(3):1058-1066.

(27) Niv MY, Rubin H, Cohen J, Tsirulnikov L, Licht T, Peretzman-Shemer A, et al. Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification. J Biol Chem 2004;279(2):1242-1255.

(28) Anis Y, Leshem O, Reuveni H, Wexler I, Ben Sasson R, Yahalom B, et al. Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia 2004;47(7):1232-1244.

(29) Licht T, Tsirulnikov L, Reuveni H, Yarnitzky T, Ben-Sasson SA. Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3). Blood 2003;102(6):2099-2107.

(30) Irony-Tur-Sinai M, Vlodavsky I, Ben-Sasson SA, Pinto F, Sicsic C, Brenner T. A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammation. J Neurol Sci 2003;206(1):49-57.

(31) Ben-Sasson SA, Grover NB. Osmosis: A macroscopic phenomenon, a microscopic view. Am J Physiol Adv Physiol Educ 2003;27(1-4):15-19.

(32) Shargal Y, Viola N, Nagler A, Merin G, Schmidt A, Buddecke E, et al. Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound. Exp Clin Cardiol 2002;7(2-3):73-79.

(33) Benezra M, Ishai-Michaeli R, Ben-Sasson SA, Vlodavsky I. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity. J Cell Physiol 2002;192(3):276-285.

(34) Strehblow C, Gyöngyösi M, Sperker W, Shirazi M, Windberger U, Pugatsch T, et al. Usefulness of intravascular ultrasound-guided histological measurements after stenting in porcine coronary artery. Coron Artery Dis 2002;13(5):291-294.

(35) Hayashi N, Liu D, Min B, Ben-Sasson SZ, Paul WE. Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells. Proc Natl Acad Sci U S A 2002;99(9):6187-6191.

(36) Ben-Sasson SZ, Zukovsky I, Biton A, Vogel R, Foucras G, Hayashi N, et al. Generation and characterization of memory CD4 T cells. Adv Exp Med Biol 2002;512:129-134.

(37) Zhang Y, Apilado R, Coleman J, Ben-Sasson S, Tsang S, Hu-Li J, et al. Interferon γ stabilizes the T helper cell type 1 phenotype. J Exp Med 2001;194(2):165-172.

(38) Shih I-, Wang T-, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A 2001;98(5):2640-2645.

(39) Ben-Sasson SZ, Gerstel R, Hu-Li J, Paul WE. Cell division is not a "clock" measuring acquisition of competence to produce IFN-γ or IL-4. J Immunol 2001;166(1):112-120.

(40) Falek PR, Ben-Sasson SZ, Ariel M. Correlation between dna methylation and murine IFN-γ and IL-4 expression. Cytokine 2000;12(3):198-206.

(41) Ben-Sasson SZ, Makedonski K, Hu-Li J, Paul WE. Survival acid cytokine polarization of naive CD4+ T cells in vitro is largely dependent on exogenous cytokines. Eur J Immunol 2000;30(5):1308-1317.

(42) Keshet E, Ben-Sasson SA. Anticancer drug targets: Approaching angiogenesis. J Clin Invest 1999;104(11):1497-1501.

(43) Weingärtner K, Ben-Sasson SA, Stewart R, Richie JP, Riedmiller H, Folkman J. Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: An in vitro model for assessment. J Urol 1998;159(2):465-470.

(44) Paul WE, Ben-Sasson SZ. Time for a new science of vaccinology - A challenge to immunologists. Immunologist 1998;6(3):100-101+105+128.

(45) Katz A, Vlodavsky I, Davies M, Miao H-, Ben-Sasson SA, Darmon D, et al. Antiproliferative activity to glomerular mesangial cells and receptor binding of a heparin-mimicking polyaromatic anionic compound. J Am Soc Nephrol 1997;8(11):1688-1697.

(46) Huang H, Hu-Li J, Chen H, Ben-Sasson SZ, Paul WE. IL-4 and IL-13 Production in Differentiated T Helper Type 2 Cells Is Not IL-4 Dependent. J Immunol 1997;159(8):3731-3738.

(47) Miao H-, Ornitz DM, Aingorn E, Ben-Sasson SA, Vlodavsky I. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound. J Clin Invest 1997;99(7):1565-1575.

(48) Huang H, Hu-Li J, Ben-Sasson SZ, Seder R, Paul WE. A stat-6- binding element in the IL-4 promoter. FASEB J 1996;10(6).

(49) Mire-Sluis AR, Das RG, Thorpe R, Thomas S, Maher D, Valent P, et al. Implications for the assay and biological properties of interleukin-3. Results of a WHO international collaborative study. J Immunol Methods 1996;194(1):1-12.

(50) Mire-Sluis AR, Das RG, Thorpe R, Thomas S, Maher D, Valent P, et al. Implications for the assay and biological activity of interleukin-4. Results of a WHO international collaborative study. J Immunol Methods 1996;194(1):13-25.

(51) Nadir E, Margalit H, Gallily T, Ben-Sasson SA. Microsatellite spreading in the human genome: Evolutionary mechanisms and structural implications. Proc Natl Acad Sci U S A 1996;93(13):6470-6475.

(52) Ben-Sasson SA, Sherman Y, Gavrieli Y. Identification of Dying Cells—In Situ Staining. Methods Cell Biol 1995;46(C):29-39.

(53) Vlodavsky I, Miao H-, Atzmon R, Levi E, Zimmermann J, Bar-Shavit R, et al. Control of cell proliferation by heparan sulfate and heparin-binding growth factors. Thromb Haemost 1995;74(1):534-540.

(54) Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baehr PH, Rosen S, et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 1995;47(6):1806-1810.

(55) Beller U, Haimovitch R, Ben-Sasson S. Periovulatory multifocal mesothelial proliferation: A possible association with malignant transformation. Int J Gynecol Cancer 1995;5(4):306-309.

(56) Margalit H, Nadir E, Ben-Sasson SA. A complete Alu element within the coding sequence of a central gene. Cell 1994;78(2):173-174.

(57) Benezra M, Ben-Sasson SA, Regan J, Chang M, Bar-Shavit R, Vlodavsky I. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds. Arterioscler Thromb Vasc Biol 1994;14(12):1992-1999.

(58) Davis DL, Ben-Sasson S, Antognini JF, Kassirer JP. Do Medical Journals Suppress Information? New Engl J Med 1993;328(7):510-511.

(59) Regan JR, Bruno JG, Chang MN, Sabatino R, D'alisa R, Ben-Sasson SA, et al. Mimicry of Biological Macromolecules by Polyaromatic Anionic Compounds. J Bioact Compat Polym 1993;8(4):317-337.

(60) Arad-Dann H, Beller U, Haimovitch R, Gavrieli Y, Ben-Sasson SA. Immunohistochemistry of phosphotyrosine residues: Identification of distinct intracellular patterns in epithelial and steroidogenic tissues. J Histochem Cytochem 1993;41(4):513-519.

(61) Margalit H, Fischer N, Ben-Sasson SA. Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. J Biol Chem 1993;268(26):19228-19231.

(62) Gross A, Ben-Sasson SZ, Paul WE. Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. J Immunol 1993;150(6):2112-2120.

(63) Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119(3):493-501.

(64) Ben-Sasson SA, Davis DL. The authors' reply. Cancer Causes Control 1992;3(6):582.

(65) Ben-Sasson SA, Davis DL. Neonatal exposure to protoporphyrin-activating lighting as a contributing cause of childhood acute lymphocytic leukemia. Cancer Causes Control 1992;3(4):383-387.

(66) Benezra M, Vlodavsky I, Ben-Sasson S. Reversal of Basic Fibroblast Growth Factor-mediated Autocrine Cell Transformation by Aromatic Anionic Compounds. Cancer Res 1992;52(20):5656-5662.

(67) Seder RA, Boulay J-, Finkelman F, Barbier S, Ben-Sasson SZ, Le Gros G, et al. CD8+ T cells can be primed in vitro to produce IL-4. J Immunol 1992;148(6):1652-1656.

(68) Seder RA, Paul WE, Ben-Sasson SZ, Legros GS, Plaut M, Ben-Sasson SZ, et al. Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils. Int Arch Allergy Immunol 1991;94(1-4):137-140.

(69) Tanaka T, Ben-Sasson SZ, Paul WE. IL-4 increases IL-2 production by T cells in response to accessory cell-independent stimuli. J Immunol 1991;146(11):3831-3839.

(70) Seder RA, le Gros G, Ben‐Sasson SZ, Urban J, Finkelman FD, Paul WE. Increased frequency of interleukin 4‐producing T cells as a result of polyclonal priming. Use of a single‐cell assay to detect interleukin 4‐producing cells. Eur J Immunol 1991;21(5):1241-1247.

(71) Gros GL, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (114)-producing cells in vivo and in vitro: IIr2 and ILr4 are required for in vitro generation of U-4-producing cells. J Exp Med 1990;172(3):921-929.

(72) Conrad DH, Ben-Sasson SZ, Le Gros G, Finkelman FD, Paul WE. Infection with Nippostrongylus Brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells. J Exp Med 1990;171(5):1497-1508.

(73) Ben-Sasson SZ, Gros GLE, Conrad DH, Finkeeman FD, Paul WE. Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines. Proc Natl Acad Sci U S A 1990;87(4):1421-1425.

(74) Ben-Sasson SZ, Le Gros G, Conrad DH, Finkelman FD, Paul WE. IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J Immunol 1990;145(4):1127-1136.

(75) Le Gros G, Ben-Sasson SZ, Conrad DH, Clark-Lewis I, Finkelman FD, Plaut M, et al. IL-3 Promotes production of IL-4 by splenic non-B, non-T cells in response to Fc receptor cross-linkage. J Immunol 1990;145(8):2500-2506.

(76) Morecki S, Slavin S, Ben-Sasson SA. Selective abrogation of alloreactivity via priming in the presence of aphidicolin, a specific inhibitor of DNA polymerase. J Immunol 1989;143(3):838-843.

(77) Ben-Chetrit E, Eilat D, Ben-Sasson SA. Specific inhibition of the DNA-anti-DNA immune reaction by low molecular weight anionic compounds. Immunology 1988;65(3):479-485.

(78) Shapira-Nahor O, Eynat E, Ben-Sasson SZ. Isotype specificity of antigen-specific helper clone in vivo. J Immunol 1987;139(1):35-41.

(79) Szigeti R, Kagan-Haion K, Klein E, Ben-Sasson SZ. Radiation leukemia virus-transformed immunocompetent T cells. II. Antigen-induced macrophage migration inhibition factor and leukocyte migration inhibition factor production. Cell Immunol 1986;102(1):89-98.

(80) Ben-Sasson SA, Cohen T, Voss R. Background allelic variants in normal hemopoietic cells and Bloom's syndrome erythrocytes and the possible implication of somatic crossingover. Cancer Genet Cytogenet 1985;15(3-4):237-242.

(81) Azar Y, Falek PR, Kagan J, Ben-Sasson SZ. In vivo activity of affinity-purified helper factor from antigen-specific helper clone. J Immunol 1985;134(3):1717-1722.

(82) Ben-Sasson SZ, Saito H, Uchida T, Dorf ME. Antigen-specific murine T-cell lymphomas. II. H-2 Restriction of primary and secondary responses. Cell Immunol 1984;89(2):290-299.

(83) Guy R, Ben-Sasson SZ. Antigen-specific helper factor production by immortalized clone of OVA-specific T cells. I. In vitro activity. Cell Immunol 1984;89(1):186-193.

(84) Ben-Sasson SA, Henkart PA. Generation of selective microenvironment at the cell periphery through bulk-phase hydrophilic polymers. Biochim Biophys Acta Mol Cell Res 1983;763(2):99-106.

(85) Azar Y, Ben-Sasson SZ. In vivo helper activity of enriched populations of antigen-specific T lymphocytes. Cell Immunol 1983;79(1):150-156.

(86) Grover NB, Ben Sasson SA, Naaman J. Electrical sizing of particles in suspensions. V. High electric fields. Anal Quant Cytol 1982;4(4):302-308.

(87) Ben Sasson SA, Naaman J, Grover NB. Membrane changes induced by high electric fields. Evidence for sulfhydryl group involvement. Anal Quant Cytol 1982;4(4):309-314.

(88) Eidelzstein PR, Ben-Sasson SZ. The role of non-specific lymphocytes in antigen-induced proliferative response in vitro. J Immunol Methods 1982;53(1):27-39.

(89) Yefenof E, Azar Y, Eidelsztein P, Ben-Sasson SZ. Immortalization of antigen specific, helper T cell lines by transformation with the radiation leukemia virus (RadLV). J Immunol 1982;128(2):625-628.

(90) Azar Y, Eidelsztein P, Yefenof E, Chriqui E, Katz-Gross A, Kedar E, et al. Antigen-specific murine T-cell lymphomas: Functional heterogenicity. Cell Immunol 1981;65(1):194-200.

(91) Ben-Sasson SZ, Kagan J. In vitro selection of murine antigen-specific T-lymphocytes. I. Description of selection procedure. J Immunol Methods 1981;42(3):291-304.

(92) Ben-Sasson SZ, Kagan J. Antigen-induced proliferation of murine T-lymphocytes in vitro. II. The effect of different macrophage populations on the antigen-induced proliferative response. J Immunol Methods 1981;41(3):321-331.

(93) Hamburger J, Ben-Sasson SA. Serobiological differentiation between antischistosomal (Schistosoma mansoni) antisera. Tropenmed Parasitol 1981;32(1):43-47.

(94) Kettman J, Ben-Sasson S. Immune response of guinea pig lymphoid cells in vitro. III. Induction by Concanavalin A of a secondary anti-TNP response in primed guinea pig cells. Cell Immunol 1980;50(1):216-223.

(95) Kagan J, Ben-Sasson SZ. Antigen-induced proliferation of murine T-lymphocytes in vitro. I. Characterization of the lymphocyte culture system. J Immunol Methods 1980;37(1):15-27.

(96) Ray A, Ben-Sasson S. Recognition of DNP-amino acid determinants by primed guinea pig T cells. Cell Immunol 1980;53(1):173-181.

(97) Ray A, Ben-Sasson S. Antigen structural requirements for activation of a T-cell-mediated antibenzenearsonate immune response. Mol Immunol 1980;17(8):1011-1018.

(98) Laufer N, Grover NB, Ben-Sasson S, Freund H. Effects of adenosine diphosphate, colchicine and temperature on size of human platelets. Thromb Haemost 1979;41(3):491-497.

(99) Ben-Sasson SA. Immunoglobulin differentiation is dictated by repeated recombination sequences within the V region prototype gene: A hypothesis. Proc Natl Acad Sci U S A 1979;76(9):4598-4602.

(100) Ray A, Ben-Sasson S. The separate roles of hapten and of carrier in the conformation of T cell-reactive determinants on ABA-protein conjugates. J Immunol 1979;122(5):1960-1966.

(101) Ben-Sasson SZ, Lipscomb MF, Tucker TF, Uhr JW. Specific binding of T lymphocytes to macrophages. III. Spontaneous dissociation of T cells from antigen-pulsed macrophages. J Immunol 1978;120(6):1902-1906.

(102) Kettman J, Ben-Sasson S, Rudin JU. Primary immune response of guinea pig spleen cells in vitro. J Immunol Methods 1978;20(C):131-141.

(103) Ben-Sasson SZ, Lipscomb MF, Tucker TF, Uhr JW. Specific binding of T lymphocytes to macrophages. II. Role of macrophage-associated antigen. J Immunol 1977;119(4):1493-1500.

(104) Lipscomb MF, Ben Sasson SZ, Uhr JW. Specific binding of T lymphocytes to macrophages. I. Kinetics of binding. J Immunol 1977;118(5):1748-1754.

(105) Ben Sasson SA, Henkart PA. Enhancement of weak mixed lymphocyte type reactions by hydrophilic polymers. J Immunol 1977;119(1):227-231.

(106) Ben Sasson SZ, Paul WE. Selection and enrichment of antigen specific T lymphocyte populations: a review. Isr J Med Sci 1976;12(4-5):414-424.

(107) Ben Sasson SZ, Paul WE, Shevach EM, Green I. In vitro selection and extended culture of antigen specific T lymphocytes. II. Mechanisms of selection. J Immunol 1975;115(6):1723-1730.

(108) Shevach E, Ben-Sasson SZ, Finkelman F, Paul WE, Green I. Mechanisms of action of genes controlling the immune response. Transplant Proc 1975;7(2):141-147.

(109) Ben Sasson SZ, Paul WE, Shevach EM, Green I. In vitro selection and extended culture of antigen specific T lymphocytes. I. Description of selection culture procedure and initial characterization of selected cells. J Exp Med 1975;142(1):90-105.

(110) Shevach EM, Finkelman F, Ben‐Sasson SZ, Green I, Paul WE. Ir GENES AND ANTIGEN RECOGNITION. Ann New York Acad Sci 1975;249(1):541-547.

(111) Ben-Sasson S, Shaviv R, Bentwich Z, Slavin S, Doljanski F. Osmotic behavior of normal and leukemic lymphocytes. Blood 1975;46(6):891-899.

(112) Janeway Jr CA, Cohen BE, Ben Sasson SZ, Paul WE. The specificity of cellular immune responses in guinea pigs. I. T cells specific for 2,4 dinitrophenyl O tyrosyl residues. J Exp Med 1975;141(1):42-55.

(113) Ben-Sasson SZ, Shevach E, Green I, Paul WE. Alloantiserum-induced inhibition of migration inhibition factor production in immune response gene-controlled immune systems. J Exp Med 1974;140(2):383-395.

(114) Doljanski F, Ben‐Sasson S, Reich M, Grover NB. Dynamic osmotic behavior of chick blood lymphocytes. J Cell Physiol 1974;84(2):215-223.

(115) Ben‐Sasson S, Patinkin D, Grover NB, Doljanski F. Electrical sizing of particles in suspensions IV. Lymphocytes. J Cell Physiol 1974;84(2):205-214.

(116) Grover NB, Naaman J, Ben-Sasson S, Doljanski F. Electrical Sizing of Particles in Suspensions: III. Rigid Spheroids and Red Blood Cells. Biophys J 1972;12(9):1099-1116.

(117) Grover NB, Naaman J, Ben-Sasson S, Doljanski F. Electrical Sizing of Particles in Suspensions: I. Theory. Biophys J 1969;9(11):1398-1414.

(118) Grover NB, Naaman J, Ben-Sasson S, Doljanski F, Nadav E. Electrical Sizing of Particles in Suspensions: II. Experiments with Rigid Spheres. Biophys J 1969;9(11):1415-1425.